These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

108 related items for PubMed ID: 5577479

  • 1. Symposium on levodopa in Parkinson's disease. Clinical and pharmacological aspects. Introduction.
    McDowell F.
    Clin Pharmacol Ther; 1971; 12(2):317-8. PubMed ID: 5577479
    [No Abstract] [Full Text] [Related]

  • 2. Symposium on levodopa in Parkinson's disease. Clinical and pharmacological aspects. Where do we go from here?
    Clin Pharmacol Ther; 1971; 12(2):408-16. PubMed ID: 5577487
    [No Abstract] [Full Text] [Related]

  • 3. Symposium on levodopa in Parkinson's disease. Clinical and pharmacological aspects. Clinical laboratory abnormalities.
    McDowell F.
    Clin Pharmacol Ther; 1971; 12(2):335-9. PubMed ID: 4102803
    [No Abstract] [Full Text] [Related]

  • 4. [Clinical results with levodopa in Parkinson's disease].
    Crudeli R.
    Sist Nerv; 1970; 22(2):124-5. PubMed ID: 5504551
    [No Abstract] [Full Text] [Related]

  • 5. [Levodopa and Parkinson's disease].
    Rinne UK.
    Duodecim; 1971; 87(12):929-32. PubMed ID: 5088231
    [No Abstract] [Full Text] [Related]

  • 6. Long-term treatment of Parkinson's disease with levodopa.
    Campbell JB.
    Neurology; 1970 Dec; 20(12):18-22. PubMed ID: 5531291
    [No Abstract] [Full Text] [Related]

  • 7. [Treatment of Parkinson's syndrome with levodopa].
    Rossi CA.
    Prensa Med Argent; 1970 Oct 02; 57(31):1516-8. PubMed ID: 5485492
    [No Abstract] [Full Text] [Related]

  • 8. [Drug therapy of Parkinson's disease with amantadine and levodopa].
    Fieschi C, Nardini M, Casacchia M, Reitano M, Tedone ME, Ferrari P, Robotti E.
    Sist Nerv; 1970 Oct 02; 22(2):126-43. PubMed ID: 5504552
    [No Abstract] [Full Text] [Related]

  • 9. [Electrophysiological effect of Levodopa on the phenomena of spinal inhibition and facilitation in Parkinson's disease].
    Cernibori.
    Riv Neurol; 1970 Oct 02; 40(5):303-9. PubMed ID: 5503723
    [No Abstract] [Full Text] [Related]

  • 10. [The therapeutic use of L-DOPA in Parkinson's disease. Biochemical, pharmacological and clinical considerations].
    Morselli PL, Rizzo M, Tognoni G.
    Recenti Prog Med; 1970 Feb 02; 48(2):97-124. PubMed ID: 5467589
    [No Abstract] [Full Text] [Related]

  • 11. [Results of treatment with levodopa and rehabilitative therapy in 10 cases of Parkinson's disease].
    Paciaroni E, Raspa EG.
    Sist Nerv; 1970 Feb 02; 22(2):153-61. PubMed ID: 5504554
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Etiology and therapy of Parkinson's syndrome and related pharmacological concepts shown in experimental models].
    Oehme P, Schwarz K.
    Dtsch Gesundheitsw; 1966 Apr 28; 21(17):792-8. PubMed ID: 5929188
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [L-dopa in the treatment of Parkinson's disease].
    Völler G.
    Med Welt; 1970 Jul 04; 27():1267-8. PubMed ID: 5512643
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.